PharmTech Drug Digest 11.20
News|Articles|October 19, 2016

Oxford Genetics Opens New Facility to Support R&D in Cell and Gene Therapy

Oxford Genetics increased its laboratory space to 5700 sq. ft. with a move to a new location at Oxford Science Park.

On Oct. 19, 2016, Oxford Genetics announced that it has moved operations to a new laboratory in the Oxford Science Park. The company, which specializes in DNA design, protein expression optimization, and cell-line development is moving from its previous location at Begbroke Science Park to the Medawar Centre. This move increases Oxford Genetics laboratory space to 5700 sq ft. The company’s ongoing growth strategy is to expand its operations to support new services for cancer fighting technologies.

In a press announcement, Oxford Genetics said it will use the new location to increase research and development into services to support cell and gene therapy. The new facilities will also include dedicated cell development suites and new robotic platforms for process automation. This will allow Oxford Genetics to scale its services, following an increase in demand.

Source: Oxford Genetics 


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.